CFTR involvement in the pathogenesis of pulmonary arterial hypertension

L. To (Le Plessis-Robinson, France), H. Leribeuz (Le Plessis-Robinson, France), M. Ghigna (LE PLESSIS ROBINSON, France), M. Lambert (Le Plessis-Robinson, France), C. Martin (Le Plessis-Robinson, France), P. Burgel (Le Plessis-Robinson, France), A. Boët (Le Plessis-Robinson, France), F. Becq (Le Plessis-Robinson, France), J. Issard (Le Plessis-Robinson, France), C. Pechoux (Le Plessis-Robinson, France), B. Manoury (Le Plessis-Robinson, France), O. Mercier (Le Plessis-Robinson, France), F. Perros (Le Plessis-Robinson, France), M. Humbert (Le Plessis-Robinson, France), D. Montani (Le Plessis-Robinson, France), F. Antigny (Le Plessis-Robinson, France)

Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Session: Experimental approaches to pulmonary hypertension
Session type: E-poster session
Number: 1478
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. To (Le Plessis-Robinson, France), H. Leribeuz (Le Plessis-Robinson, France), M. Ghigna (LE PLESSIS ROBINSON, France), M. Lambert (Le Plessis-Robinson, France), C. Martin (Le Plessis-Robinson, France), P. Burgel (Le Plessis-Robinson, France), A. Boët (Le Plessis-Robinson, France), F. Becq (Le Plessis-Robinson, France), J. Issard (Le Plessis-Robinson, France), C. Pechoux (Le Plessis-Robinson, France), B. Manoury (Le Plessis-Robinson, France), O. Mercier (Le Plessis-Robinson, France), F. Perros (Le Plessis-Robinson, France), M. Humbert (Le Plessis-Robinson, France), D. Montani (Le Plessis-Robinson, France), F. Antigny (Le Plessis-Robinson, France). CFTR involvement in the pathogenesis of pulmonary arterial hypertension. 1478

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (5) 2000653; 10.1183/13993003.00653-2020
Year: 2021



Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (2) 2101645; 10.1183/13993003.01645-2021
Year: 2021



The role of fractalkine in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009


Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension
Source: Eur Respir J 2010; 35: 6-8
Year: 2010


Novel treatment for pulmonary vascular disease: lessons from pathophysiology
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006


Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012


Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
Source: Eur Respir Rev 2009; 19: 59-63
Year: 2010



Contribution of angiopoietin/Tie2 pathway to pulmonary artery smooth muscle hyperplasia in idiopathic pulmonary hypertension
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005


First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension
Source: Eur Respir J, 51 (3) 1701694; 10.1183/13993003.01694-2017
Year: 2018



Towards an understanding of pulmonary arterial hypertension (PAH): gene regulation patterns in pulmonary arterial resistance vessels of patients with PAH
Source: Eur Respir J 2006; 28: Suppl. 50, 526s
Year: 2006

Single arterial occlusion to locate resistance in patients with pulmonary hypertension
Source: Eur Respir J 2003; 21: 31-36
Year: 2003



Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010

Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature
Source: Eur Respir J 2014; 44: 1275-1288
Year: 2014



Endothelial NO and its pathophysiologic regulation
Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease
Year: 2007


Endothelial cells in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020
Year: 2021



The Role of Inflammation in promoting pulmonary hypertension in idiopatchi and connective tissue disease-associated PAH
Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension
Year: 2008


Exercise pathophysiology in patients with pulmonary arterial hypertension
Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease
Year: 2007


Diagnosis of pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005

Pulmonary hypertension in sickle cell disease
Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease
Year: 2007